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BANGLADESH: Using strong evidence and
strategic collaboration to increase access
to menstrual regulation with medication
FROM EVIDENCE TO IMPACT: A look at how STEP UP
research was used to impact policies and programmes
The goal of family planning and reproductive health operations research is not merely to
generate evidence but also to inform policies and programmes to solve the problems of
women’s access to and quality of services. Yet the crucial step of ensuring the utilization
of that evidence often receives inconsistent or inadequate attention. There is relatively
little monitoring and reporting on whether and to what effect project results are utilized, or
on the nature, process, and efficacy of the strategies employed to achieve this.
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SUMMARY
Through close cooperation with the Ministry of
Health and Family Welfare (MoH&FW) of the
People’s Republic of Bangladesh, and other
partners, STEP UP generated strong evidence
and cultivated ongoing collaboration that
contributed to policy changes and programme
expansions. These changes are increasing
women’s access to menstrual regulation with
medication (MRM) in Bangladesh, and include:
 Approval of MRM services introduction in the
national family planning program
 Approval of MRM scale up nationwide in
public facilities, and creation of strategic plan
for scale up;
 Development of national MRM service
delivery guidelines and training curriculum;
 MRM combination drugs locally manufactured
for first time;

Training of Master Trainers

STEP UP generates
policy-relevant research
to promote an evidencebased approach for
improving access to
family planning and
safe abortion.

The aim of this case study is to present an activity of the STEP UP research programme
consortium that resulted in successful evidence utilization. This is to both demonstrate
the positive impact STEP UP is having on family planning and reproductive health
policies and programmes, as well as to document the process by which this was
achieved so as to inform future research of successful strategies and lessons learned.

 Memorandum of Understanding signed
with the Director General of Family
Planning to assist in scale up MRM
services to nearly 4,000 health facilities;
 Development of a core group of 13 master
trainers and trained service providers in
MRM service provision (108 physicians
and 126 family welfare visitors from
Maternal and Child Welfare Centres
(MCWCs); and
 Successful service expansion to 70 urban
MCWCs and in all urban health and family
welfare centres of two districts

INTRODUCTION
Despite the availability of effective modern contraceptive
methods in Bangladesh, the number of unsafe abortions
rises each year, increasing risk of maternal morbidity and
mortality.1,2
Menstrual regulation (MR) is an interim method of safely
establishing non-pregnancy after a missed period,
regardless of whether conception has occurred or not, and
is usually done without a pregnancy test. Its availability
helps to decrease the number of women who have unsafe
abortions – and consequently, decreases maternal
mortality and morbidity.3 Indeed, effective implementation
of the MR policy in Bangladesh has contributed to a
reduction in maternal mortality from 24% to 11% between
1976 and 2005.4 In Bangladesh, MR is typically conducted
using manual vacuum aspiration (MVA), a surgical
method.
However, MR using MVA carries risks of social stigma and
significant post-MVA complications if service quality is
poor or unhygienic. Despite the fact that MR using MVA is
a safe and legal service that is widely available in most
public health facilities, approximately 650,000 women
each year are unable to access this service – prompting
them to resort to more discreet but illegal induced
abortions, most of which are unsafe.2 Addressing the
barriers that prevent women from using MR services
would reduce illegal and unsafe abortion and the
associated mortality and morbidity.
Menstrual regulation with medication (MRM) is an
important tool for achieving non-pregnancy after a missed
period. MRM is a safe, WHO-approved, non-invasive
alternative to MVA. The most effective drug formulation for
MRM is a Misoprostol-Mifepristone combination.

Pre and post training tests

However, MRM is not yet widely available in Bangladesh.
By increasing access to this simple and safe MR option,
women’s morbidity due to MR and unsafe abortion in
Bangladesh could be greatly decreased.

Menstrual regulation with medication (MRM) is
a safe, WHO-approved, non-invasive
alternative to MVA that is approved in
Bangladesh but not yet widely available. By
increasing access to this simple and safe MR
option, women’s morbidity due to MR and
unsafe abortion could be greatly decreased.

THE PROJECTS
STEP UP partners in Bangladesh have worked to
understand the barriers to MRM access and identify
possible solutions. Our projects have explored (1) why
women undergo induced and/or unsafe abortions and
what barriers they face to accessing legal MR, and (2) the
feasibility of introducing MRM in Bangladesh as a solution,
and the acceptability of providing MRM using the
Mifepristone-Misoprostol drug combination in urban and
rural public health facilities.
Understanding unintended pregnancy in Bangladesh:
Country Profile: STEP UP conducted an extensive review
and critical analysis of literature on existing MR and
abortion policies and programmes in Bangladesh, seeking
to understand why and how women undergo unsafe
abortions and why they do not obtain MR. Relevant local
research-based organisations were consulted, pertinent
documents were collected, and PubMed/MEDLINE,
HINARI, JSTOR and Google Scholar were searched.5
icddr,b has also developed a stakeholder analysis which
provides information about factors that contribute to
pregnancy termination in Bangladesh and about a range
factors that contributed to the approval process of MRM in
Bangladesh.6
Assessing the feasibility and acceptability of
introducing MRM in Bangladesh: In collaboration with
the Directorate General of Family Planning (DGFP) and
the World Health Organisation, STEP UP partners tested
the feasibility and acceptability of introducing MRM using
the Mifepristone-Misoprostol drug combination in urban
and rural public health facilities. An 18-month operations
research study was conducted from January 2012 to June
2013. Health facilities were selected with high numbers of
MR clients and available trained service providers.1 All
women who visited the 13 health facilities for MR services

from October 2012 -- May 2013 were invited to
participate in the study. All women were counseled by
trained service providers about the advantages,
disadvantages, and side effects of MR and given a
choice between MVA and MRM to regulate
menstruation.1

KEY STUDY FINDINGS

Testing the feasibility and
acceptability of introducing MRM into
rural and urban public health facilities




Understanding barriers to women’s
access to MR and recourse to unsafe
abortion
 MR services (MVA) are available at the majority of
public facilities at district, sub-district, and union
levels, as well as at some private and NGO facilities.
 Women are deterred from seeking MR services due
to distance to the facility, unofficial fees for the
service, lack of privacy and risk of stigma, and
negative provider attitudes.5
 As of 2011, 10,600 doctors and 7,200 paramedics
(mainly family welfare visitors) had been trained to
provide MR services through MVA, yet a minority of
the providers trained to provide MR actually do so.5, 7
 26% of women seeking MR are rejected by
providers. Most providers indicated that the women
had exceeded the then-legal time limit of 10 weeks
since their last menstrual period, but many rejected
women for discriminatory reasons.
 Many of these providers refuse to provide MR
services because of personal feelings, including: if
the woman is childless (20%), if they felt she was too
young (12%) if she is unmarried, widowed, or
divorced (8%) or if she lacks consent from her
husband or guardian, although this is only legally
required for minors or the mentally handicapped
(7%).5, 8
 Few women (11%) obtain MR free of charge, despite
the fact that public-sector MR is supposed to be
available at no cost.5
 Adolescent girls – especially those who are
unmarried – are at higher risk of unsafe abortion.
One study indicated that the risk of abortion for
unmarried adolescents was 35 times greater than
among those who are married. This may be due to
high stigma against unmarried pregnancy, or to
inadequate adolescent awareness of reproductive
health resources including MR. Sex workers are also
at higher risk of unsafe abortion.5, 9






Nearly all providers identified the last menstrual
period and 70% took a menstrual history. The overall
quality of services provided at these health facilities
was high.
One in five clients experienced a side effect
(commonly nausea) after taking Mifepristone (first
dose), although less than half of these women
required medication or further treatment for the side
effects.
Almost two-thirds of women preferred MRM to MVA.
Nearly all women who chose MRM (97%) reported
that they would suggest MRM to their friends and
relatives; 95% would refer a friend to the same
facility. Virtually all women receiving MRM reported
being satisfied/very satisfied with the quality of care.
The vast majority (92%) of women returned to the
facility after 14 days for the examination to confirm
procedure completion.1

The study suggested that it is safe and feasible to
introduce MRM in Bangladesh in rural and urban public
health facilities.1

MAKING AN IMPACT
Influencing policy and programme
improvements
The legalization, introduction, and expansion of MRM in
Bangladesh has been made possible by the collaborative
efforts of many local, national, and international
stakeholders, of which STEP UP is one. Specific to our
efforts, focused stakeholder engagement and utilization of
study findings contributes to several impacts:
MRM approved for introduction and scale-up in
national family planning programme
Findings of the study were presented at the 61st National
Technical Committee (NTC) meeting and it was
subsequently approved by the NTC and Drug
Administration that the combination MRM drug
(Mifepristone-Misoprostol) be introduced into the national
family planning programme. It was approved in this
meeting that initial introduction be initiated by phases,
starting in urban areas.10 It was also requested by DGFP
that STEP UP provide technical assistance during the
scale up phases to ensure availability of MRM services
through trained health care providers.

Memorandum of Understanding signed to scale up
MRM nationwide after initial introduction
Based on discussions during the NTC meeting, a
tripartite Memorandum of Understanding (MOU) was
signed between the Directorate General of Family
Planning (DGFP) under the MoH&FW, Bangladesh, and
STEP UP partners (Population Council and MSI) to scale
up MRM throughout Bangladesh.

Strategic plan for MRM service scale-up created
STEP UP assisted the DGFP in the development of a
strategic plan for the vertical expansion of MRM services
in the nearly 4,000 MCWCs and UH&FWCs. The DGFP
will carry out this expansion starting with the incorporation
of MRM services into their 5th HNP sector programme.
The scale up programme has been completed in all 70
MCWCs and two districts of Khulna Division.

In this MOU, STEP UP agreed to provide technical
assistance for the scaling up of MRM services to all
(nearly 4,000) Maternal and Child Welfare Centres
(MCWCs) and Union Health and Family Welfare Centres
(UH&FWCs), to support the implementation process, and
to assist the DGFP to ensure the availability of the
required commodities. Subsequently, a project advisory
committee (PAC) and technical group were formed to
support STEP UP in carrying out this agreement.

Master Trainers identified and trained
One of the major objectives of MRM scale-up activities
was to develop a national pool of Master Trainers (MTs)
on MRM who can be utilized during the nationwide
services expansion. The MTs were selected by the PAC
and were from DGFP, DGHS, OGSB, MSB and
Population Council. All MTs were physicians and had
previous extensive experience on training on MR service
provision. A total of 13 MTs were trained.

National service delivery guidelines and training
curriculum developed
As agreed in the MOU, the DGFP formed a technical
committee (including the DGFP, DGHS, Obstetrical and
Gynecological Society of Bangladesh, RH STEP, Marie
Stopes Bangladesh, Ipas, and BAPSA) to develop
national service delivery guideline for MRM. STEP UP
worked within the technical committee as well as with
local experts to develop the service delivery guidelines
and a training curriculum for MRM service providers.
These guidelines and curricula were finalized and
approved by the PAC, translated into Bengali, and are
being used to provide consistent information to different
cadres of service providers.

Dr. Farid Uddin Ahmed, Assistant Director, MCH-Service
Unit, DGFP in a training session

Urban service providers trained in MRM provision
While testing the feasibility of providing MRM services to
women in public health facilities, STEP UP trained all
eligible providers in 70 urban Maternal and Child Welfare
Centres in safe provision of MRM services. A total of 108
physicians and 126 FWVs were trained.
MRM combination drugs supplied to 70 MCWCs
With support from WHO, Marie Stopes supplied MRM
combinations drugs to all 70 MCWCs. A total of 12,000
combinations drugs were supplied, a one-year supply.
MRM training expanded into rural areas
Further, STEP UP organized an orientation and training
programmes in Khulna Division to underpin the DGFP’s
scale-up of services according to the strategic plan. Sixty
(60) programme managers of 10 districts of Khulna
Division received training in MRM service provision and
28 medical officers for maternal and child health and
family planning (MOMCH) were trained as trainers to
enable subsequent provider training (which was
supported by two Master Trainers from the Ministry of
Health and Family Welfare).
Training on MRM was further expanded to Family Welfare
Visitors (FWVs) and female Sub Assistant Community
Medical Officers (SACMOs) of Khulna and Jessore
District. Training was conducted by a government Master
Trainer and two medical officers (MOMCH) who had
participated in the Training of Trainers programme. A total
of 73 FWVs from UH&FWCs and 6 female SACMOs in
both districts.

MRM combination drugs locally manufactured
for first time
After the approval of MRM drugs by the Directorate
general of Drug Administration (DGDA), several local
pharmaceutical companies in Bangladesh started
manufacturing the Misoprostol/Mifepristone combination
drug. Now, it is manufactured by several companies.
This change stands to promote women’s access to MRM
commodities by making drugs more readily available to
local providers, reducing stock outs, and improving the
supply chain.

Who will benefit?
 Women in need of safe, accessible MRM
services: Having access to quality MRM services
may help women in Bangladesh to avoid resorting to
invasive procedures like MVA or unsafe methods of
pregnancy terminations. This stands to help prevent
women’s illness, injury, and even death. Further,
before the addition of MRM to the method mix, only
MVA was available. Adding more options gives
women the freedom to choose the method that is
right for them.
 Public health facilities: If women increasingly use
MRM instead of MVA or unsafe methods of
pregnancy termination, fewer women may need to
be treated for complications from these procedures,
thus reducing the burden placed upon clinics that
may be overworked and underfunded. Furthermore,
by increasing the number of providers who can
provide MRM, improving their training, and improving
the availability of supplies, public health facilities
may provide better services more reliably.

HOW WAS IMPACT ACHIEVED?
SOME KEY LESSONS LEARNED
Close collaboration with government
and professional societies
Critical to STEP UP’s impact in Bangladesh has been a
close and ongoing collaboration with both government
ministries as well as with professional organisations.
Importantly, the project team sought to ensure these
individual relationships remained positive, cooperative,
reliable, and were productive rather than obstructive.
STEP UP activities also have had the support and
participation from not only the broad membership of these
groups but from individuals in leadership roles.
The Ministry of Health and Family Welfare, specifically
the Dr. Nur Hossain Talukder (Director General, DGFP),
and Dr. Mohammed Sharif (Director, MCH Services Unit,
DGFP) took an active role in organizing and
implementing the MRM training programme. This
included the formation of a technical working group,
hosting the training programme and providing resource
persons, and the DGFP inaugurating and closing each
training session.
STEP UP also collaborated closely with the Obstetrical
and Gynaecological Society of Bangladesh (OGSB). The
OGSB played an important role in developing the service
delivery guidelines, reviewing information education and
communication (IEC) materials, and providing training to
the service providers. Former OGSB President Dr.
Rashwan Ara and Secretary General Dr. Farhana Dewan
actively participated in developing the service delivery
guideline, selection of Master Trainers and providing
training to Master Trainers. Furthermore, former
president of the OGSB Dr. Latifa Samsuddin attended
each training session.
When the STEP UP team proposed policy adoption
before the NTC, it was done in collaboration with local
policy makers and programme managers. This dynamic
of partnership, inclusivity, and responsiveness to
identified local needs was key in successful adoption of
policies.

FWVs training session

Strong project partnership featuring a
range of expertise and resources
Marie Stopes Bangladesh (MSB), the Population Council,
and OGSB brought unique strengths to a productive
partnership, which was significant in helping to promote
MRM policy adoption. That MSB is a service delivery
agency was valuable in helping to make the study’s
recommendations feasible and acceptable to the
MOHFW. MSB was able to facilitate clinical training
sessions, procure and supply the necessary MRM drugs
to the DGFP, and serve as referral centres to provide
backup support to referred MRM clients of government
facilities for management of side effects or complications.
Population Council research, in addition to data gathered
by icddr,b, contributed strong evidence that helped to
underpin the merit of the policy and programme changes
made to support MRM service provision. The Council
also helped to lead in the design, organisation, and
implementation of the overall MRM scale up activities,
logistical support and knowledge management, including
the development of two databases of service providers
posted to MCWCs, aiding in effective communication for
selection of participants in MRM training.

Sound evidence that reflected a
receptive public, engaged service
providers, and supportive policy
environment
Studies carried out by STEP UP and others generated
strong evidence indicating that women vastly preferred
MRM over MVA – especially the ease, safety, and
privacy of MRM.1 Furthermore, although some service
providers decline to provide MRM, the majority indicated
that being able to offer MRM would enable them to better
serve women for whom MVA was an inappropriate
option, or when MVA supplies were limited.11 They
expressed excitement about MRM as a welcome, safer,
in-demand service that they wanted to be able to offer
women.12 Providers and clients alike perceived MRM as
a non-invasive, more suitable, technologically-simple,
and easy-to-use alternative method to MVA.6
In addition, linking project activities to evidence and
recommendations from WHO – as a respected and
globally-acknowledged authority on the issue – helped to
affirm STEP UP’s findings and recommendations as
credible among providers and policymakers.

Professor Dr. Latifa Samsuddin, immediate past President,
OGSB conducting session

The DGFP was keen to introduce an alternative to MVA,
reflected in their commitment to support STEP UP
research and formalizing an MOU with Population
Council and MSB. Their support was continually borne
out throughout STEP UP’s research and training
processes; the MCH-Services unit has taken active roles
in organizing and implementing the MRM training
program, has formed a project advisory committee to
guide, monitor and supervise the programme activities,
has formed a technical working group to guide
development of guidelines and IEC materials, and hosts
and staffs the MRM training programmes.

DISCUSSION
Achieving impact through research uptake hinged on
several strategies that enabled the project partners to
identify and pursue the relevant local mechanisms for
policy adoption. These strategies included:




Close collaboration with government and
professional societies
Strong project partnership featuring a range of
experience and resources
Strong evidence generated that reflected a receptive
public, open-minded service providers, and
supportive policy environment

It was important for STEP UP to underpin the above
efforts by focusing on the dynamics with which they
engaged policymakers. By cultivating sensitive
interpersonal dynamics that paid attention to policy maker
priorities, concerns, obstacles, and opportunities, STEP
UP partners were able to build trust, strategically frame
recommendations and their intended outcomes in positive
terms that focused on shared goals, prioritize
participation of policymakers and managers in evidence
gathering, and generally ensure that personal
relationships with stakeholders and policymakers
remained pleasant, cooperative, and reliable.

CONCLUSION
Although nearly all contraceptive methods are approved
and available in Bangladesh, each year unintended
pregnancies compel women to resort to unsafe methods
of pregnancy termination. MR is a procedure that uses
MVA to safely establish nonpregnancy after a missed
period, but is not suitable for all women. MVA can be
unsafe when the quality of service is poor, administered
by inadequately trained service providers in unhygienic
settings. Menstrual Regulation with Medication (MRM) is a
safe, effective, low-cost alternative to MVA that is vastly
preferred by both women and providers.
The most effective drug formulation for MRM is a
Misoprostol-Mifepristone drug combination. Previous to
STEP UP’s activities, the drug Misoprostol had been
available in Bangladesh for several non-MRM uses.
However, Mifepristone was not approved as it was
branded as abortifacient. Through collaborative advocacy
efforts and strong evidence, the combined drug was
approved for use in MRM services, is being locally
manufactured, and is being used in nationwide scale up of
MRM service delivery.
Now that it is clear that MRM is acceptable and effective
in Bangladesh, has been legalized and folded into the
national FP program, and is being scaled up nationwide,
ongoing observation and studies are still needed. It is
important to understand whether the efficacy and
acceptability of MRM remains the case when services are
delivered at scale on a national level. Follow-up studies
should gather data on who is seeking services, whether
they are doing it correctly, how frequently they are doing
it, what complications they face (if any), are whether they
are getting enough attention if there is a complication.
Additionally, although the government is coordinating
nationwide scale up in public facilities, we must consider
the role that the private sector plays in women’s access to
MRM, especially considering that the government has
little control over the drugs sold in pharmacies. Although
the drugs are not approved for sale over-the-counter,
pharmaceutical companies are aggressively marketing
Misoprostol to pharmacists, despite the fact that they may
not be properly trained and the fact that Misoprostol is
less effective for MRM than the combination drug.

MRM kit available in Bangladesh
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